Carsten Hagemann

2.7k total citations
74 papers, 2.0k citations indexed

About

Carsten Hagemann is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, Carsten Hagemann has authored 74 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Molecular Biology, 23 papers in Genetics and 16 papers in Oncology. Recurrent topics in Carsten Hagemann's work include Glioma Diagnosis and Treatment (23 papers), Barrier Structure and Function Studies (11 papers) and Meningioma and schwannoma management (9 papers). Carsten Hagemann is often cited by papers focused on Glioma Diagnosis and Treatment (23 papers), Barrier Structure and Function Studies (11 papers) and Meningioma and schwannoma management (9 papers). Carsten Hagemann collaborates with scholars based in Germany, United Kingdom and United States. Carsten Hagemann's co-authors include Ulf R. Rapp, Jonathan L. Blank, Mario Löhr, Ralf‐Ingo Ernestus, Giles H. Vince, Almuth F. Keßler, Jelena Anacker, Michael Flentje, Harun M. Said and K. Roosen and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer Research.

In The Last Decade

Carsten Hagemann

73 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Carsten Hagemann Germany 26 1.1k 419 404 320 237 74 2.0k
Brett W. Stringer Australia 25 1.1k 1.0× 536 1.3× 398 1.0× 476 1.5× 167 0.7× 61 1.9k
Marta Mellai Italy 26 910 0.8× 411 1.0× 346 0.9× 633 2.0× 246 1.0× 57 1.8k
Chunhui Di United States 18 1.2k 1.0× 353 0.8× 440 1.1× 510 1.6× 267 1.1× 26 2.0k
Xiangqi Meng China 23 1.2k 1.1× 692 1.7× 379 0.9× 310 1.0× 344 1.5× 59 2.0k
Ana C. deCarvalho United States 25 1.1k 1.0× 698 1.7× 456 1.1× 481 1.5× 163 0.7× 44 2.0k
Persio Dello Sbarba Italy 29 1.1k 1.0× 552 1.3× 442 1.1× 418 1.3× 446 1.9× 78 2.3k
Mark A. Eckert United States 19 1.7k 1.6× 798 1.9× 608 1.5× 293 0.9× 169 0.7× 32 2.7k
Elisabetta Rovida Italy 28 1.1k 0.9× 365 0.9× 395 1.0× 209 0.7× 419 1.8× 78 2.0k
Giuseppe Lamorte Italy 22 1.5k 1.3× 441 1.1× 804 2.0× 526 1.6× 245 1.0× 44 2.5k
Ulf D. Kahlert Germany 27 1.3k 1.2× 830 2.0× 563 1.4× 589 1.8× 236 1.0× 99 2.4k

Countries citing papers authored by Carsten Hagemann

Since Specialization
Citations

This map shows the geographic impact of Carsten Hagemann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carsten Hagemann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carsten Hagemann more than expected).

Fields of papers citing papers by Carsten Hagemann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carsten Hagemann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carsten Hagemann. The network helps show where Carsten Hagemann may publish in the future.

Co-authorship network of co-authors of Carsten Hagemann

This figure shows the co-authorship network connecting the top 25 collaborators of Carsten Hagemann. A scholar is included among the top collaborators of Carsten Hagemann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carsten Hagemann. Carsten Hagemann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Vergote, Ignace, Teresa Macarulla, Fred R. Hirsch, Carsten Hagemann, & David S. Miller. (2023). Tumor Treating Fields (TTFields) Therapy Concomitant with Taxanes for Cancer Treatment. Cancers. 15(3). 636–636. 12 indexed citations
3.
Nerreter, Thomas, Carsten Hagemann, Ralf‐Ingo Ernestus, et al.. (2023). Characterization and Optimization of the Tumor Microenvironment in Patient-Derived Organotypic Slices and Organoid Models of Glioblastoma. Cancers. 15(10). 2698–2698. 5 indexed citations
4.
Salvador, Ellaine, Almuth F. Keßler, Małgorzata Burek, et al.. (2023). EFFECTS OF TUMOR TREATING FIELDS ON IMMORTALIZED HUMAN PERICYTES IN AN IN VITRO BLOOD-BRAIN BARRIER (BBB) MODEL. IBRO Neuroscience Reports. 15. S639–S639. 1 indexed citations
5.
Monoranu, Camelia Maria, Pia Herrmann, Ralf‐Ingo Ernestus, et al.. (2023). Metastasis Associated in Colorectal Cancer 1 (MACC1) mRNA Expression Is Enhanced in Sporadic Vestibular Schwannoma and Correlates to Deafness. Cancers. 15(16). 4089–4089. 2 indexed citations
6.
Salvador, Ellaine, Polina Bugaeva, Almuth F. Keßler, et al.. (2023). Tumor Treating Fields (TTFields) Induce Cell Junction Alterations in a Human 3D In Vitro Model of the Blood-Brain Barrier. Pharmaceutics. 15(1). 185–185. 19 indexed citations
7.
Moser, Justin C., Ellaine Salvador, Kenneth D. Swanson, et al.. (2022). The Mechanisms of Action of Tumor Treating Fields. Cancer Research. 82(20). 3650–3658. 65 indexed citations
8.
Salvador, Ellaine, Almuth F. Keßler, Małgorzata Burek, et al.. (2022). Tumor Treating Fields (TTFields) Reversibly Permeabilize the Blood–Brain Barrier In Vitro and In Vivo. Biomolecules. 12(10). 1348–1348. 31 indexed citations
9.
Salvador, Ellaine, Almuth F. Keßler, Małgorzata Burek, et al.. (2021). Abstract 279: Transient opening of the blood brain barrier by Tumor Treating Fields (TTFields). Cancer Research. 81(13_Supplement). 279–279. 2 indexed citations
10.
Salvador, Ellaine, Małgorzata Burek, Mario Löhr, et al.. (2021). Senescence and associated blood–brain barrier alterations in vitro. Histochemistry and Cell Biology. 156(3). 283–292. 22 indexed citations
11.
Hagemann, Carsten, Mathias Dahlmann, Almuth F. Keßler, et al.. (2019). Circulating MACC1 Transcripts in Glioblastoma Patients Predict Prognosis and Treatment Response. Cancers. 11(6). 825–825. 9 indexed citations
12.
Keßler, Almuth F., Ellaine Salvador, Małgorzata Burek, et al.. (2019). EXTH-02. THE BLOOD BRAIN BARRIER (BBB) PERMEABILITY IS ALTERED BY TUMOR TREATING FIELDS (TTFIELDS) IN VIVO. Neuro-Oncology. 21(Supplement_6). vi82–vi82. 5 indexed citations
13.
Keßler, Almuth F., Ellaine Salvador, Małgorzata Burek, et al.. (2019). Blood Brain Barrier (BBB) Integrity Is Affected By Tumor Treating Fields (TTFields) in Vitro and In Vivo. International Journal of Radiation Oncology*Biology*Physics. 105(1). S162–S163. 10 indexed citations
14.
Löhr, Mario, Antje Technau, Jürgen Krauß, et al.. (2018). High-grade glioma associated immunosuppression does not prevent immune responses induced by therapeutic vaccines in combination with Treg depletion. Cancer Immunology Immunotherapy. 67(10). 1545–1558. 18 indexed citations
15.
Hagemann, Carsten, et al.. (2017). High-Efficiency Transfection of Glioblastoma Cells and a Simple Spheroid Migration Assay. Methods in molecular biology. 1622. 63–79. 2 indexed citations
16.
Linsenmann, Thomas, Camelia Maria Monoranu, Giles H. Vince, et al.. (2014). Long-term tumor control of spinal dissemination of cerebellar glioblastoma multiforme by combined adjuvant bevacizumab antibody therapy: a case report. BMC Research Notes. 7(1). 496–496. 7 indexed citations
17.
Hagemann, Carsten, et al.. (2006). High efficiency transfection of glioma cell lines and primary cells for overexpression and RNAi experiments. Journal of Neuroscience Methods. 156(1-2). 194–202. 20 indexed citations
18.
Hagemann, Carsten, Andreas Kalmes, Viktor Wixler, et al.. (1997). The regulatory subunit of protein kinase CK2 is a specific A‐Raf activator. FEBS Letters. 403(2). 200–202. 84 indexed citations
19.
20.
Gautheron, P., M. Cottin, Geoff Haynes, et al.. (1994). Interlaboratory assessment of the bovine corneal opacity and permeability (BCOP) assay. Toxicology in Vitro. 8(3). 381–392. 72 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Brett W. Stringer Breakdown of academic impact, for papers by Marta Mellai Breakdown of academic impact, for papers by Chunhui Di Breakdown of academic impact, for papers by Xiangqi Meng Breakdown of academic impact, for papers by Ana C. deCarvalho Breakdown of academic impact, for papers by Persio Dello Sbarba Breakdown of academic impact, for papers by Mark A. Eckert Breakdown of academic impact, for papers by Elisabetta Rovida Breakdown of academic impact, for papers by Giuseppe Lamorte Breakdown of academic impact, for papers by Ulf D. Kahlert
Rankless by CCL
2026